ftInvstr

SPARC · Healthcare ₹199.8 -1.04% Mkt Cap ₹6579 Cr

SPARC

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹199.8

-1.04% today · 30d -7.92%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for SPARC. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹40 Cr

+314.11% YoY

NET PROFIT

₹-21 Cr

OPM

-16.26%

+212.38pp YoY

EPS

₹-0.64

PE 4.22

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-4.0% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

SPARC4.22164.0

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 90

Valuation CHEAP 90

Growth STRONG 77

Profitability DECENT 52

Technicals NEUTRAL 55

Risk MODERATE 50

Key Stats

TTM PE

4.22

P/B

4.99

52W HIGH

₹289.0

OFF HIGH

-30.87%

MKT CAP

₹6579 Cr

◉ Active Signals

MACDNeutral1.4918

RSI(14)Neutral45.51

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SPARC and at what entry.